Locally Advanced Renal Cell Carcinoma: Clinical Trials

5 trials for Locally Advanced Renal Cell Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 completed, 1 terminated, 1 withdrawn. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Recruiting 2, Completed 1, Terminated 1
Phase 12Recruiting 1, Withdrawn 1

Follow Locally Advanced Renal Cell Carcinoma: new trials by email Literature Review of Locally Advanced Renal Cell Carcinoma trials Research Report on Locally Advanced Renal Cell Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
Aldesleukin, Biopsy, Biospecimen Collection - Locally Advanced Cervical Carcinoma, Locally Advanced Colorectal Carcinoma
Phase 1WithdrawnCity of Hope Medical Center2025-12-052025-12-24
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Zanzalintinib, Nivolumab - Locally Advanced Renal Cell Carcinoma
Phase 2RecruitingQian Qin692025-10-302026-09-04
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 1 / Phase 2RecruitingMayo Clinic1382022-03-312026-08-20
A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)
Retifanlimab - Metastatic Non-small Cell Lung Cancer, Locally Advanced Urothelial Cancer
Phase 2CompletedIncyte Corporation1212019-01-092023-07-21
Optimizing Pazopanib Exposure in RCC Patients
Pazopanib - Locally Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
Phase 2TerminatedInteressenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e.62014-02-252017-08-18

Narrower conditions

Carcinoma, Renal Cell (4)  ·  Melanoma (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Neoplasm Metastasis (2)  ·  Uterine Cervical Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Lobular (1)  ·  Carcinoma, Merkel Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Carcinosarcoma (1)  ·  Clear-cell metastatic renal cell carcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Endometrial Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Pancreatic Neoplasms (1)

Broader conditions

Adenocarcinoma (4)  ·  Carcinoma (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Kidney Diseases (4)  ·  Kidney Neoplasms (4)  ·  Male Urogenital Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Urologic Diseases (4)  ·  Urologic Neoplasms (4)

Interventions

Biopsy (2)  ·  Cyclophosphamide (2)  ·  Magnetic Resonance Spectroscopy (2)  ·  Specimen Handling (2)  ·  Colony-Stimulating Factors (1)  ·  Immunoglobulin G (1)  ·  Nivolumab (1)  ·  X-Rays (1)  ·  aldesleukin (1)  ·  fludarabine (1)  ·  pazopanib (1)  ·  pembrolizumab (1)  ·  sargramostim (1)

Sponsors

City of Hope Medical Center (1)  ·  Incyte Corporation (1)  ·  Interessenverband zur Qualitätssicherung der Arbeit niedergelassener Uro-Onkologen in Deutschland e. (1)  ·  Mayo Clinic (1)  ·  Qian Qin (1)

Countries

United States (3)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Romania (1)  ·  Spain (1)

Top investigators

Goetz Geiges, MD (1)  ·  Mark Cornfeld, MD (1)  ·  Qian Qin, MD (1)  ·  Vincent Chung (1)  ·  Yanyan Lou, MD, PhD (1)

NIH funding

P30CA033572 (1)